An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213875
Company: AUROBINDO PHARMA LTD

Products on ANDA 213875

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	25MG	CAPSULE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213875

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/19/2021	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 213875

DICLOFENAC POTASSIUM

CAPSULE;ORAL; 25MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	25MG	CAPSULE;ORAL	Prescription	No	AB	213875	AUROBINDO PHARMA LTD
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	25MG	CAPSULE;ORAL	Prescription	No	AB	204648	BIONPHARMA
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	25MG	CAPSULE;ORAL	Prescription	No	AB	210078	STRIDES PHARMA
ZIPSOR	DICLOFENAC POTASSIUM	25MG	CAPSULE;ORAL	Prescription	Yes	AB	022202	ASSERTIO

Top